Viz.ai Named to Forbes AI 50 List of Top Artificial Intelligence Companies of...
Only company in healthcare to be recognized for the fourth time SAN FRANCISCO – April 12, 2023- Viz.ai, the leader...
Apr 12, 2023
All Resources
Explore our latest resources
April 6, 2023
Top 3 Takeaways from the Health Equity in Clinical Trials Congress
Panelists share their perspectives on how ethically trained AI can combat bias within the healthcare system, leading to greater access...
Mar 31, 2023
Viz.ai Launches Viz™ Trauma Suite to Support Change in Trauma Center Standards
Tailored for trauma care providers to help expedite patient care and improve outcomes SAN FRANCISCO--March 29, 2023 --Viz.ai, the leader...
Mar 29, 2023
Viz.ai is First to Receive FDA 510(k) Clearance for AI Algorithm for Abdominal...
New artificial intelligence algorithm flags and triages suspected abdominal aortic aneurysms SAN FRANCISCO – March 21, 2023- Viz.ai, the leader...
Mar 21, 2023
Viz.ai Named One of Fierce Medtech’s “Fierce 15” Companies of 2022
Annual list recognizes innovative medtech companies that are advancing the art and science of healthcare SAN FRANCISCO – March 20,...
Mar 20, 2023
Key Takeaways from the SIR 2023 Annual Scientific Meeting
This year, Viz.ai had the pleasure of attending and connecting with interventional and diagnostic radiologists from all across the world...
Mar 13, 2023
Viz.ai to Expedite Patient Enrollment in NIH-funded PE-TRACT Clinical Trial
Viz.ai’s AI-powered clinical research platform will be used to find, screen and enroll patients in a landmark study of catheter-directed...
Mar 04, 2023
Viz.ai Announces Agreement with Bristol Myers Squibb to Enable Earlier Detection and Management...
Viz.ai has submitted a de novo classification request to the FDA for a new AI algorithm intended to identify and...
Mar 02, 2023